Data review showed that the study was underpowered to draw clear conlcusions

This is a pilot study assessing the role of the general practitioner in performing follow-up reviews on men who have recently completed radical radiotherapy for prostate cancer. This will be measured primarily by assessing any changes to the patient's health-related quality of life which will be evaluated by the completion of questionnaires by the participant at each review visit. The study aims to confirm that patient outcome is identical, independent of whether follow-up is performed by a specialist or the patient's General Practitioner.

Inclusion Criteria:

• Men with a tumour T1-3 stage prostate cancer and have had radical radiotherapy with curative intent
• Are between six and twelve months post-treatment completion
• Have completed all treatment for prostate cancer (including hormonal deprivation therapy)
• Have no evidence of metastatic disease
• ECOG performance status of between 0-1
• Remains willing to comply with study requirements
• Has maintained contact with an individual general practitioner

Exclusion Criteria:

• Persistent complications resulting from treatment defined as a minimum Grade 3 treatment toxicity
• Unable to complete self-administered questionnaires
• Are currently enrolled in a study that requires specialist follow-up
• Life expectancy of less than 6 months
• Surgery to remove the prostate
• Evidence of biochemical failure

Men approximately six months post-completion of radical radiotherapy treatment for prostate cancer who have not experienced significant treatment toxicities or disease progression.